Comparative proteomic analyses of human adipose extracellular matrices decellularized using alternative procedures by Porch-Thomas, Caasy et al.
Western University 
Scholarship@Western 
Anatomy and Cell Biology Publications Anatomy and Cell Biology Department 
9-2018 
Comparative proteomic analyses of human adipose extracellular 
matrices decellularized using alternative procedures 
Caasy Porch-Thomas 
Biomedical Science Program, Tulane University School of Medicine & Center for Stem Cell Research & 
Regenerative Medicine, Tulane University School of Medicine 
Jie Li 
Center for Stem Cell Research & Regenerative Medicine, Tulane University School of Medicine & National 
Engineering Laboratory for Oral Regenerative Medicine, West China School of Stomatology, Sichuan 
University 
Fabiana Zanata 
Center for Stem Cell Research & Regenerative Medicine, Tulane University School of Medicine & Federal 
University of Sao Paulo 
Elizabeth C. Martin 
Department of Biological and Agricultural Engineering, Louisiana State University 
Nicholas Pashos 
Center for Stem Cell Research & Regenerative Medicine, Tulane University School of Medicine 
See next page for additional authors Follow this and additional works at: https://ir.lib.uwo.ca/anatomypub 
 Part of the Anatomy Commons, and the Cell and Developmental Biology Commons 
Citation of this paper: 
Porch-Thomas, Caasy; Li, Jie; Zanata, Fabiana; Martin, Elizabeth C.; Pashos, Nicholas; Genemaras, 
Kaylynn; Poche, Nicholas J.; Totaro, Nicholas P.; Bratton, Melyssa R.; Gaupp, Dina; Frazier, Trivia; Wu, 
Xiying; Ferreira, Lydia Masako; Tian, Weidong; Wang, Guangdi; Bunnell, Bruce A.; Flynn, Lauren; Hayes, 
Daniel; and Gimble, Jeffrey M., "Comparative proteomic analyses of human adipose extracellular matrices 
decellularized using alternative procedures" (2018). Anatomy and Cell Biology Publications. 207. 
https://ir.lib.uwo.ca/anatomypub/207 
Authors 
Caasy Porch-Thomas, Jie Li, Fabiana Zanata, Elizabeth C. Martin, Nicholas Pashos, Kaylynn Genemaras, 
Nicholas J. Poche, Nicholas P. Totaro, Melyssa R. Bratton, Dina Gaupp, Trivia Frazier, Xiying Wu, Lydia 
Masako Ferreira, Weidong Tian, Guangdi Wang, Bruce A. Bunnell, Lauren Flynn, Daniel Hayes, and Jeffrey 
M. Gimble 
This article is available at Scholarship@Western: https://ir.lib.uwo.ca/anatomypub/207 
Comparative Proteomic Analyses of Human Adipose 
Extracellular Matrices Decellularized Using Alternative 
Procedures
Caasy Thomas-Porch1,2, Jie Li2,3, Fabiana Zanata2,4, Elizabeth C. Martin5, Nicholas 
Pashos2, Kaylynn Genemaras2, J. Nicholas Poche5, Nicholas P. Totaro5, Melyssa R. 
Bratton6, Dina Gaupp2, Trivia Frazier2,7,8, Xiying Wu7, Lydia Masako Ferreira4, Weidong 
Tian3, Guangdi Wang6, Bruce A. Bunnell2,9, Lauren Flynn10,11, Daniel Hayes12, and Jeffrey 
M. Gimble2,7,8,13,14
1Biomedical Science Program, Tulane University School of Medicine, New Orleans, LA
2Center for Stem Cell Research & Regenerative Medicine, Tulane University School of Medicine, 
New Orleans, LA
3National Engineering Laboratory for Oral Regenerative Medicine, West China School of 
Stomatology, Sichuan University, Chengdu, China
4Federal University of Sao Paulo, Sao Paulo, SP, Brazil
5Department of Agricultural and Biological Engineering, Louisiana State University, Baton Rouge, 
LA
6Department of Chemistry, Xavier University of Louisiana, New Orleans LA
7LaCell LLC, New Orleans LA
8Department of Structural and Cell Biology, Tulane University School of Medicine, New Orleans, 
LA
9Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA
10Department of Chemical and Biochemical Engineering, Western University, London, ON, 
Canada
11Department of Anatomy and Cell Biology, Western University, London, ON, Canada
12Department of Biomedical Engineering, Pennsylvania State University, State College, PA
13Department of Medicine, Tulane University School of Medicine, New Orleans, LA
14Department of Surgery, Tulane University School of Medicine, New Orleans, LA
Abstract
Decellularized human adipose tissue has potential clinical utility as a processed biological scaffold 
for soft tissue cosmesis, grafting and reconstruction. Adipose tissue decellularization has been 
accomplished using enzymatic-, detergent-, and/or solvent-based methods. To examine the 
hypothesis that distinct decellularization processes may yield scaffolds with differing 
compositions, the current study employed mass spectrometry to compare the proteomes of human 
adipose-derived matrices generated through three independent methods combining enzymatic-, 
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detergent-, and/or solvent-based steps. In addition to protein content, bioscaffolds were evaluated 
for DNA depletion, ECM composition, and physical structure using optical density, histochemical 
staining, and scanning electron microscopy (SEM). Mass spectrometry (MS) based proteomic 
analyses identified 25 proteins (having at least two peptide sequences detected) in the scaffolds 
generated with an enzymatic approach, 143 with the detergent approach, and 102 with the solvent 
approach, as compared to 155 detected in unprocessed native human fat. Immunohistochemical 
detection confirmed the presence of the structural proteins actin, collagen type VI, fibrillin, 
laminin, and vimentin. Subsequent in vivo analysis of the predominantly enzymatic- and 
detergent-based decellularized scaffolds following subcutaneous implantation in GFP+ transgenic 
mice demonstrated that the matrices generated with both approaches supported the ingrowth of 
host-derived adipocyte progenitors and vasculature in a time dependent manner. Together, these 
results determine that decellularization methods influence the protein composition of adipose 
tissue-derived bioscaffolds.
Keywords
Adipose Tissue; Bioscaffold; Decellularization; Extracellular Matrix; Mass Spectrometry 
Proteomics; Regenerative Medicine
INTRODUCTION
Currently, plastic surgeons employ human adipose tissue as a surgical graft in wound repair, 
cosmetic and reconstructive surgeries; however, it may have broader applicability as an 
adjunct therapeutic [1]. More specifically, additional applications may include serving as a 
vehicle promoting the delivery of drugs, growth factors and/or stem cells, as well as 
representing an abundant and expendable extracellular matrix (ECM) source for generating 
bioscaffolds for both autologous and allogeneic transplantation to promote tissue 
regeneration in patients requiring cosmetic or reconstructive surgery for genetic defects of 
the breast and chest wall (Poland syndrome) [2], facial deformities (Treacher Collins 
syndrome) [3], facial lipoatrophy [4] or traumatic scar repair [5, 6]. Researchers have begun 
to develop decellularized adipose tissue products in efforts to improve long-term graft 
acceptance, differentiation, survival of transplanted stem cells and tissue regeneration [7-32]. 
Indeed, recent studies have demonstrated that decellularized adipose tissue derived 
bioscaffolds can promote the proliferation and differentiation of exogenous stromal/stem 
cells as evidenced by the expression of adipogenic lineage-specific genes in vitro, including 
PPARγ, C/EBPα, and LPL [8, 12, 29].
To extend these outcomes in a reproducible and reliable manner, it will be necessary to 
further define the composition of decellularized human adipose tissue products. One of the 
most desirable features of a decellularized tissue product would be its retention of bioactive 
ECM components such as proteoglycans and proteins including collagens, laminins, 
fibronectin, and elastin [33]. Decellularization processes will inevitably cause disruption in 
the ECM resulting in the loss of some proteins in addition to lipids, membranes and nucleic 
acids. Although these decellularization processes vary, most include enzymatic digestion, 
mechanical, and/or chemical extractions. The existing literature concerning protein analyses 
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of decellularized tissues, including adipose tissue, describes the occurrence of specific ECM 
proteins such as collagens and elastin, whose presence has been verified by biochemical and 
immunohistochemical assays [8, 12, 34].
Characterization of the adipose tissue-derived biological scaffold at the protein level is 
essential to understanding its utility, activity, and functionality. The current study compares 
adipose-derived bioscaffolds prepared using enzymatic-, detergent-, and solvent-based 
methods. The bioscaffolds were analyzed using three complementary in vitro approaches; 
histological and spectrophotometric evaluation of decellularization, qualitative 
ultrastructure, and ECM protein identification by mass spectrometry. In addition, an in vivo 
analysis of the functionality of the enzymatic and solvent based bioscaffolds was performed.
METHODS
All methods involving human samples were carried out under a protocol approved by the 
Pennington Biomedical Institutional Review Board (Baton Rouge, LA; PBRC#23040) or the 
Western Institutional Review Board (Puyallup WA: WIRB Protocol #20130449). Samples 
were obtained from male and female donors (n = 6) aged 43+/-9.3, with an average BMI of 
23.3+/-2.9 kg/m2. All subjects gave written informed consent prior to collection of their 
tissues. The hexafluorisopropanol (HFIP)-treated silk scaffolds were obtained from the 
Tissue Engineering Resource Center, Tufts University (http://ase.tufts.edu/terc/) and 
implanted as previously described [35].
Decellularization
The adipose tissue samples were divided and processed using three different 
decellularization methods.
Enzymatic-based Method 1 (M1)—Tissue samples were decellularized using a method 
developed and published by Flynn [8]. Intact adipose tissue was cut into 20-25 g pieces and 
subjected to three cycles of freeze-thaw (-80°C to 37°C) in Freezing Buffer Solution (10 
mM Tris buffer (pH 8.0), 5 mM ethylenediaminetetraacetic acid (EDTA). The tissue was 
transferred into Enzymatic Digestion Solution #1 (0.25% trypsin/0.1% EDTA), and 
incubated with agitation overnight for ~16 hrs followed by a 48 hr polar solvent extraction in 
absolute isopropanol to remove lipid content. Next the tissue was rinsed three times for 30 
minutes in Rinsing Buffer Solution (8 g/L NaCl, 200 mg/L KCl, 1 g/L Na2HPO4, and 200 
mg/L KH2PO4 (pH 8.0)), and then incubated for 6 hrs in fresh Enzymatic Digestion Solution 
#1. Following enzyme digestion, the samples were washed 3 times in Rinsing Buffer 
Solution. Next, the samples were transferred into Enzymatic Digestion Solution #2 (55 mM 
Na2HPO4, 17 mM KH2PO4, 4.9 mM MgSO4·7H2O containing 150 U/ml DNase Type II 
(from bovine pancreas), 0.125 mg/ml RNase Type III A (from bovine pancreas), and 20 
Units/ml Lipase Type VI-S (from porcine pancreas)) for 16 hrs of processing (overnight). 
The next day, samples were rinsed 3 times for 30 minutes in the Rinsing Buffer solution. 
The samples were subjected to a final polar solvent extraction in absolute isopropanol for 8 
hrs, rinsed 3 times for 30 minutes in the Rinsing Buffer solution and rinsed 3 times for 30 
minutes in 70% ethanol. Finally, the samples were stored in sterile PBS supplemented with 
1% antibiotic/antimycotic solution (ABAM) at 4°C.
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Detergent-based Method 2 (M2)—Tissue samples were decellularized using a modified 
detergent-based and xenoprotein-free method [12]. In this process, the tissue was washed in 
distilled water (1 g/mL), by shaking, for approximately 10 minutes until the wash liquid was 
clear. The sample was centrifuged at 1800 X g for 5 minutes at room temperature, and the 
upper oil layer was discarded. The viscous suspension was treated with a buffered 1 M 
solution of NaCl (0.0584 g/mL in 10 mM Tris), diluted 1:1 with the tissue, overnight in a 
37°C shaker. The following day, the samples were centrifuged at 29.3 X g for 5 minutes at 
4°C. The supernatant was decanted and the pelleted samples were rinsed with distilled water 
for 24 hrs at 4°C with gentle shaking. The medium was replaced with fresh distilled water 
the next morning, followed by continued gentle shaking at 4°C for 2 hours. The residue was 
incubated in 1 mM EDTA overnight, at room temperature. The next day the samples were 
centrifuged and washed with distilled water for 24 hours at 37°C while gently shaking. 
Finally, the samples were subjected to lysis buffer (1% tergitol type NP-40, 0.1% SDS, 5 
mM EDTA, 0.4 M NaCl, 50 mM Tris-HCl pH 8, 1 mM phenylmethylsulfonyl fluoride 
(PMSF)) (1:1 vol∷vol) overnight at 4° C to remove any remaining intact cells, centrifuged 
for 10 min, and washed with distilled water. Samples were stored in sterile distilled water at 
4°C.
Urea-based Solvent Method 3 (M3)—Tissue decellularization matched steps for the 
preparation of the commercially available ECM product, Matrigel™ as described by 
Kleinman [36]. One hundred grams of frozen adipose tissue were thawed in 200 mL of 3.4 
M NaCl buffer at room temperature. Individual samples from 2-3 donors were then 
homogenized for dispersement, followed by centrifugation at 8,000 x g for 15 minutes at 
4°C. The supernatant was discarded, the homogenization step was repeated, and 100 mL of 
2 M urea buffer (buffered with Tris) was added to the homogenate before repeating the 
homogenization step. The samples were stirred overnight at 4°C, centrifuged at 23,000 x g at 
4°C for 20 minutes, and the thick supernatant was saved on wet ice. The pellets were 
homogenized in 2 M urea buffer, centrifuged at 23,000 x g at 4°C for 20 minutes, and the 
supernatant collected. The successive supernatants from a single donor were combined and 
the pellets discarded. Next, the samples were dialyzed against two liters of tris buffered 
saline (TBS) (50 mM Tris-Cl, 150 mM NaCl pH 7.5 supplemented with 1% chloroform to 
minimize bacteria or spore contamination) for ≥ 4 hours. Samples were then dialyzed twice 
more for ≥ 2 hours each time, against 2 liters of TBS, then dialyzed once more against 2 
liters of PBS. In a sterile hood, the exterior of the dialysis bag was rinsed with 70% ethanol 
before cutting one end. The dialyzed contents were transferred into sterile conical tubes, on 
ice, and stored at 4°C until further use.
Bioscaffold Analyses
DNA extraction and quantitation—Following decellularization, all samples (n = 3 to 4 
donors) were assayed for DNA content. In a 1.5 ml micro-centrifuge tube, a 300 mg sample 
was combined with 700 μL of Lysis Buffer (50 mL of 1 M Tris at pH 8, 20 mL of 5 M NaCl, 
5 mL of 0.5 M EDTA, 100 mL of 1% SDS, and distilled deionized (DD) water to a final 
volume of 500 mL) or Proteinase Digestion Buffer (100 mM Tris pH 8.0, 200 mM NaCl, 5 
mM EDTA, 0.2% SDS) containing 10 μl proteinase K (10 mg/ml Roche) and incubated 
overnight at 55°C. The next day, the samples were extracted with 700 μL 
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phenol:chloroform:isoamyl alcohol (25:24:1), vortexed and centrifuged at 16,873 X g for 10 
minutes at room temperature. 500 μL of the supernatant was transferred to a fresh 1.5 mL 
micro-centrifuge tube, combined with 500 μL absolute ethanol, and stored at −20°C for at 
least 2 hours. The samples were then centrifuged at maximum speed for 15 minutes at 4°C 
and the supernatant was discarded. Next, the resulting DNA pellet was washed with 900 μL 
of 70% ethanol, air dried, and re-suspended in 100 μL elution buffer (EB). Samples were 
stored at −80°C until use. DNA concentration was measured via optical density, on a 











Histochemistry and Immunohistochemistry—To confirm decellularization and 
assess microscopic tissue structure and composition, histochemistry and 
immunohistochemistry were performed using modifications of previously published 
methods [37, 38]. Bioscaffold samples were fixed in 4% paraformaldehyde (PFA) and 
processed on a Thermo Scientific Excelsior ES Tissue processor. Serial sections of 5 
microns were taken. Paraffin sections were stained with Hematoxylin and Eosin (H&E) 
(Leica Microsystems, Buffalo Grove, IL) and a Masson’s Trichrome Staining Kit (Poly 
Scientific, Bay Shore, NY) according to the kit specifications. The H&E staining was 
performed using a Leica St 5020 Autostainer. Slides were scanned using a Hamamatsu 
Nanozoomer Digital Pathology (NDP) system (Hamamatsu City, Japan.)
Immunohistochemical staining for collagen VI (rabbit polyclonal IgG (1:100 dilution) 
Novus Biologicals NB120-6588), alpha smooth muscle actin (mouse monoclonal IgG2 
(1200 dilution) Millipore MAB1522), and vitronectin (mouse monoclonal IgG (1:100 
dilution) Millipore MAB1926) was performed as follows. Slides were warmed on a heating 
platform at 57°C for 30 minutes immediately prior to deparaffinization. For 
deparaffinization, slides were rinsed in the following solutions: Xylene - 2 times for 5 
minutes, 100% EtOH - 2 times for 2 minutes, 95% EtOH - 2 times for 2 minutes, 70% EtOH 
- 1 time for 2 minutes, 50% EtOH - 1 time for 2 minutes, and finally DD water - 1 time for 2 
minutes. For antigen retrieval, tissue sections were washed twice for 5 minutes in 20 mM 
Tris-HCl (pH 8.0) and incubated in a 0.4 mg/mL proteinase K solution (in Tris-HCl, pH 8.0) 
for 15 minutes at 37°C in a humidified chamber. The slides were then rinsed liberally with 
water, followed by two 5-minute washes in Tris-buffered saline with tween (TBS-T) (50 mM 
Tris, 150 mM NaCl, 0.05% Tween in DD water, pH 7.6). For antibody staining, the sections 
were covered with TBS + 10% normal serum (secondary antibody host) + 1% BSA and 
incubated for 2 hours at room temperature in a humidified chamber. Next the primary 
antibody was applied and the sections were incubated overnight at 4°C in a humidified 
chamber. The next day the slides were rinsed 2 times for 5 minutes in TBS-T. The secondary 
antibody (either goat anti-rabbit IgG or goat anti-mouse IgG at 1:200 dilution in TBS plus 
1% BSA) was applied and the sections were incubated for 1 hour at room temperature in a 
humidified chamber protected from light. The slides were then rinsed 2 times for 5 minutes 
in TBS followed by a liberal water rinse. Coverslips were added with the fluorescence-
maintaining mounting medium, Prolong+ DAPI (Life Technologies). Sections were imaged 
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using a Nikon Eclipse TE300 with an Olympus DP70 color camera in the Microbiology and 
Immunology microscopy core at the Tulane University School of Medicine.
Triglyceride Measurement—To assess residual lipid content following decellularization, 
measurements were made using a Triglyceride Colorimetric Assay kit (#10010303; Cayman 
Chemical Inc., Ann Arbor, MI). 350-400 mg of cryomilled tissue samples were minced in 2 
mL of the diluted Standard Diluent containing Halt™ protease inhibitor cocktail (Thermo 
Scientific™). The samples were then centrifuged at 10,000 x g for 10 minutes at 4°C. The 
supernatant was transferred to a second tube and stored on ice. Samples were diluted 1:10, 
1:25, 1:50, and 1:100 using the diluted Standard Diluent. Assays were prepared using 10 μL 
of standard or sample in each well of a 96 well plate. The reaction was initiated by the 
addition of 150 μL of diluted Enzyme Buffer solution to each well. The microtiter plate was 
shaken to mix the contents of the wells, covered, and incubated for 15 minutes at room 
temperature. Absorbance was measured at 540 nm on a BioRad Benchmark Plus™ plate 
reader.
Scanning Electron Microscopy—To assess tissue ultrastructure, electron microscopy 
was performed using a modification of published methods [8, 11]. In preparation for 
imaging under SEM, a ~15 mg piece of each bioscaffold was fixed in 0.2 M cacodylate at 
room temperature overnight, followed by dehydration in an increasing acetone concentration 
solution series (30% to 100%). The sample was then dried by replacing acetone with CO2 
gas and sputter-coated with platinum for 4 minutes. The samples were then imaged in the 
Socolofsky Microscopy Center, Louisiana State University on a JSM-6610LV scanning 
electron microscope.
Mass Spectrometry and Peptide Identification
Mass spectrometry and peptide analyses were performed using a modification of published 
methods [39].
Trypsinization—Protein samples were digested with sequencing grade modified trypsin 
(Promega Corp) according to the manufacturer’s instructions. Briefly, 45 μL of 200 mM 
triethyl ammonium bicarbonate (TEAB) was added to aliquots of 100 μg of protein sample 
and the final volume was adjusted to 100 μL with ultrapure water. To solubilize complex 
protein mixtures, 5 uL of 2% SDS was added before adjusting to final volume. Five 
microliters of 200 mM Tris (2-carboxyethyl) phosphine (TCEP) was added and the resulting 
mixture was incubated for 1 h at 55° C, then 5 μL of 375 mM iodoacetamide was added and 
the mixture was incubated for 30 minutes without light. After incubation, 1 mL of pre-
chilled acetone was added and the precipitation was allowed to proceed overnight at −20° C. 
The acetone-precipitated protein pellets were suspended with 100 μL of 200 mM TEAB and 
2.5 μg of trypsin was added to digest the sample overnight at 37 °C.
Fractionation of Labeled Peptide Mixture Using a Strong Cation Exchange Column
The peptide mixture was fractionated with a strong cation exchange column (SCX) (Thermo 
Scientific) on a Shimadzu 2010 HPLC equipped with a UV detector (Shimadzu, Columbus, 
MD). Mobile phase consisted of buffer A (5 mM KH2PO4, 25% acetonitrile, pH 2.8) and 
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buffer B (buffer A plus 350 mM KCl). The column was equilibrated with Buffer A for 30 
minutes before sample injection. The mobile phase gradient was set at a flow rate of 1.0 mL/
minute as follows: (a) 0 to 10 minutes: 0% buffer B; (b) 10 to 40 min: 0% to 25% Buffer B, 
(c) 40 to 45 min: 25% to 100% Buffer B; (d) 45 to 50 minutes: 100% buffer B; (e) 50 to 60 
minutes: 100% to 0% buffer B; (f) 60 minutes to 90 minutes: 0% buffer B. A total of 60 
fractions were initially collected, lyophilized and combined into 15 final fractions based on 
SCX chromatographic peaks.
Desalination of Fractionated Samples
A C18 solid-phase extraction (SPE) column (Hyper-Sep SPE Columns, Thermo-Fisher 
Scientific) was used to desalt all collected fractions. The combined 15 fractions were each 
adjusted to 1 ml final volume containing 0.25% (v/v in water) trifluoroacetic acid (TFA, 
Sigma). The C18 SPE columns were conditioned before use by filling them with 1 mL 
acetonitrile and allowing the solvent to pass through the column slowly (~3 minutes). The 
columns were then rinsed three times with 1 mL 0.25% (v/v in water) TFA solution. The 
fractions were loaded on to the top of the SPE cartridge and allowed to elute slowly. 
Columns were washed four times with 1 mL 0.25% TFA aliquots before the peptides were 
eluted with 3 × 400 μL of 80% acetonitrile/0.1% formic acid (aqueous).
LC-MS/MS Analysis on LTQ-Orbitrap
Peptides were analyzed on an LTQ-Orbitrap XL instrument (Thermo-Fisher Scientific) 
coupled to an Ultimate 3000 Dionex nanoflow LC system (Dionex, Sunnyvale, CA). High 
mass resolution was used for peptide identification and high energy collision dissociation 
(HCD) was employed for reporter ion quantification. The RP-LC system consisted of a 
peptide Cap-Trap cartridge (0.5 × 2 mm) (Michrom BioResources, Auburn, CA) and a 
prepacked BioBasic C18 PicoFrit analytical column (75 μm i.d. × 15 cm length, New 
Objective, Woburn, MA) fitted with a FortisTip emitter tip. Samples were loaded onto the 
trap cartridge and washed with mobile phase A (98% H2O, 2% acetonitrile and 0.1% formic 
acid) for concentration and desalting. Subsequently, peptides were eluted over 180 minutes 
from the analytical column via the trap cartridge using a linear gradient of 6–100% mobile 
phase B (20% H2O, 80% acetonitrile and 0.1% formic acid) at a flow-rate of 0.3 μl/minutes 
using the following gradient: 6% B for 5 minutes; 6–60% B for 125 minutes; 60–100% B for 
5 minutes; hold at 100% B for 5 minutes; 100–6% B in 2 minutes; hold at 6% B for 38 
minutes.
The LTQ-Orbitrap tandem mass spectrometer was operated in a data-dependent mode. 
Briefly, each full MS scan (60,000 resolving power) was followed by six MS/MS scans 
where the three most abundant molecular ions were dynamically selected and fragmented by 
collision-induced dissociation (CID) using a normalized collision energy of 35%, and the 
same three molecular ions were also scanned three times by HCD-MS2 with collision 
energy of 45%. MS scans were acquired in profile mode and MS/MS scans in centroid 
mode. LTQ-Orbitrap settings were as follows: spray voltage 2.0 kV, 1 microscan for MS1 
scans at 60,000 resolution (fwhm at m/z 400), microscans for MS2 at 7500 resolution (fwhm 
at m/z 400); full MS mass range, m/z 400–1400; MS/MS mass range, m/z 100–2000. The 
“FT master scan preview mode,” “Charge state screening,” “Monoisotopic precursor 
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selection,” and “Charge state rejection” were enabled so that only the 2+, 3+, and 4+ ions 
were selected and fragmented by CID and HCD.
Database Search
The protein search algorithm used was Mascot v2.3.01 (Matrix Science, Boston, Ma). 
Mascot format files were generated by the Proteome Discoverer 1.2 software (Thermo-
Fisher Scientific) using the following criteria: database, IPI_Human.fasta.v3.77 (containing 
89,422 entries and concatenated with the reversed versions of all sequences.); enzyme, 
trypsin; maximum missed cleavages, 2; Static modifications, carbamidomethylation (+57 
Da), N-terminal TMT6plex (+229 Da), lysyl TMT6plex (+229 Da). Dynamic modifications, 
N-terminal Clnpyro- Glu (+17Da); methionine oxidation (+16 Da); STY phosphorylation 
(+80 Da); Precursor mass tolerance was set at 20 ppm; fragment match tolerance was set at 
0.8 Da. Peptides reported by the search engine were accepted only if they met the false 
discovery rate of p < 0.05 (target decoy database), a Mascot ion score ≥30 for peptide 
identifications was required.
Gene Ontology Analysis—Identification of retained proteins and associated molecular 
mechanisms was performed through the free online data base DAVID Bioinformatics [40, 
41] . Protein identifiers where converted to gene name prior to analysis and GOTERM BP-
FAT was used for each decellularization type.
In Vivo Implantation
Murine studies examining the implantation of the decellularized adipose tissue (DAT) 
scaffolds were conducted in accordance with IACUC Protocol #4302 which had been 
reviewed and approved by the Tulane University Institutional Animal Care and Use 
Committee (IACUC) prior to the initiation of this work.
The DAT was cut into sections with the dimensions of 10 × 10 × 5 mm or 500 μL total 
volume, rinsed repeatedly in 70% ethanol, and rehydrated twice in sterile PBS. Prior to 
implantation, GFP+C57Bl/6 mice were anesthetized with 2% isoflurane in 2 L/minute of O2. 
The dorsal hair was shaved and one 1 cm incision was placed in the midline dorsal skin of 
the mice. The M1 and M2 decellularized adipose ECM as well as silk scaffolds were 
carefully placed in subcutaneous pockets on the back of each animal using tweezers as 
described in [42]. Each mouse received 4 implants (two per side bilaterally adjacent to the 
spinal cord), with duplicate scaffolds prepared for each of three donors and a total of 12 
mice in the study. All animals were housed in separate cages using standard husbandry 
conditions of 12 h light/12 h dark, room temperature of 20° to 21°C and unlimited access to 
food and water. The animals were sacrificed after three, six and nine weeks post-
implantation and implanted scaffolds were collected within their surrounding tissues. The 
explanted scaffold samples were fixed in 4% paraformaldehyde and processed on a tissue 
processor (Thermo Scientific Excelsior ES Tissue processor). Serial sections of 5 μm were 
stained with Hematoxylin and Eosin (H&E) (Leica Microsystems, Buffalo Grove, IL and 
Leica St 5020 Autostainer). For the immunohistochemistry study, the paraffin embedded and 
fixed sections were stained using GFP (Anti-GFP rabbit polyclonal antibody unconjugated 2 
mg/mL 100 uL, Invitrogen Molecular Probes, Eugene, Oregon, USA), perilipin (Rb pAb to 
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Perilipin A 110 uL, Abcam, Cambridge, MA, USA) and CD31 (DSHB Hybridoma Product 
2H8, Ames, Iowa, USA) antibodies according to the protocol described in the 
Histochemistry and Immunohistochemistry section above. Sections were imaged using Scan 
Scope Console – Leica, Version 10.2.0.2314 and Image Scan Scope – Leica, Biosystems, 
2006-2013, Version 12.1.0.5029 and Aperio eSlide Manager online desktop Scan Scope 
Console software.
Statistics—Outcomes are reported as the mean ± standard deviation unless otherwise 
indicated. Comparisons are based on the student t-test with significance defined as p < 0.05 
performed with Excel (Microsoft, Redmond WA).
RESULTS
Decellularization and Physical Characterization
The three decellularized scaffold preparations, enzymatic-based Method 1 (M1), detergent-
based Method 2 (M2), and solvent-based Method 3- Matrigel™ (M3), underwent 
characterization studies to determine DNA content removal, resulting physical structure, and 
retained protein composition. Following the decellularization steps, the bioscaffolds 
displayed the following overall macroscopic appearances: whitish color with retention of 
tissue volume (M1); yellowish color with contracted tissue volume (M2) and; whitish color 
with loss of tissue architecture and appearance of a suspension (M3). Staining with H&E 
and Masson’s trichrome was performed to qualitatively assess cell nuclei and tissue structure 
in the untreated adipose tissue relative to the decellularized adipose tissues. Histochemical 
staining documented the presence of nuclei in the untreated tissues, and a lack of nuclei 
following the M1, M2 and M3 decellularization procedures (Figure 1). To further evaluate 
the presence of retained nuclear content, optical density readings were taken for quantitative 
measurements of genomic DNA remaining in the decellularized bioscaffolds relative to 
untreated tissue (Table 1). Relative to the genomic DNA isolated from the untreated control 
(281 ± 152 ng/μL), the M1 (47 ± 27 ng/μL) and M2 (37 ± 9 ng/μL) decellularization 
methods significantly reduced the genomic DNA content while the M3 method (237 ± 221 
ng/μL) did not. To evaluate residual lipid content following decellularization, lipid vacuole 
shape and triglyceride content were next evaluated. Lipid vacuoles appeared as imperfect 
spheres in M1 and M2 bioscaffolds, similar to that of native tissue; however, these structures 
were less apparent within M3 scaffolds (H&E staining; Figure 1); this may reflect the 
presence of urea in the M3 protocol or, alternatively, may be an artifact of sectioning. 
Triglyceride measurements indicated that all three decellularization methods retained less 
than fifty-percent of the triglyceride content relative to the untreated native tissue (Table 1).
To further evaluate the effect of decellularization, scaffolds prepared with all Methods were 
stained with Masson’s Trichrome (Figure 1). The level of Masson’s Trichrome staining was 
enriched following M1 and M2 decellularization methods but not M3 relative to the 
untreated control. To qualitatively assess the collagen fiber structure in the processed 
samples, scanning electron microscopy (SEM) was performed (Figure 1). SEM under M2 
and M3 revealed a complex fibrous network with varied patterns and densities on the surface 
of the bioscaffolds relative to the untreated control tissue. In contrast, SEM under M1 
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appeared to display smaller collagen bundles; however, this may reflect regional differences 
within the fixed specimen. To further determine the retained cell and matrix composition, 
immunofluorescent staining for collagen VI, actin, and vitronectin was performed using M1 
and M2 scaffolds (Figure 2). Consistent with mass spectrometry results, collagen VI gave 
the strongest positive signal in control and decellularized tissues. In contrast, actin signal 
was reduced in both M1 and M2 while vitronectin, although present in M1, was nearly 
absent in M2 relative to the untreated tissue control. The M3 scaffolds were not examined 
due to failure of the bioscaffold suspension to properly mount onto the slides.
Mass Spectrometry and Immunohistochemical Proteomic Characterization
Mass spectrometry proteomic analyses provided an unbiased global assessment of the 
protein content of the bioscaffolds. The untreated tissue sample had a reading of 281 
peptides; of these, 155 were identified by the detection of at least two (2+) peptides and 29 
were associated with the detection of seven (7+) peptides (Table 2 and Supplementary Table 
1). The M1 sample had a reading of 67 total peptides identified, with 25 having 2+ peptide 
sequences detected and only one having 7+ peptides detected (Supplementary Table 2). The 
M2 scaffold had a reading of 296 total peptides, 143 of which had 2+ peptides detected, and 
30 of these had 7+ peptides detected (Supplementary Table 3). The M3 scaffold sample had 
243 total peptides, with 102 having 2+ peptides detected and 15 having 7+ peptides detected 
(Supplementary Table 4). We evaluated the top twenty peptides (by number of peptides 
detected) from each sample for commonalities (Supplemental Table 5), as well as protein 
localization comparisons (Figure 3). Comparisons of the top twenty peptides identified in 
the untreated tissue and decellularized scaffolds by the different methods revealed that these 
were localized to the blood, nucleus, cytoskeleton, extracellular space, other various 
intracellular locales, and those whose locations were unidentified. Inquiries were performed 
to identify key factors in the ECM composition and to determine if they were associated 
with a pathological biomarker or pathway. No markers or pathways were identified that 
associated with particular diseases or pathologies. DAVID bioinformatics was used to 
identify gene ontology analysis based on the genes assumed or known to be associated with 
the proteins identified by LC MS/MS, to determine functionality of the components of the 
final scaffold products. Analysis of total protein content determined that constituents 
remaining in all three scaffold preparation method products showed association with cell 
adhesion, biological adhesion, wound response, protein complex assembly, and 
macromolecular complex assembly- among others (Table 3). Full gene ontology lists of the 
individual scaffold preparation methods can be found in the supplemental material 
(Supplemental Table 6). Identification of protein ontology uniquely identified only with 
tissue decellularization and not present in native tissue, demonstrated enrichment for 
proteins associated with biological and cell adhesion as well as lipid metabolism and DNA 
packaging. Proteins included within this are: Isoform 1 of Myosin-9, Basement membrane-
specific heparan sulfate proteoglycan core protein, Histone H3.3, Isoform 2 of Hormone-
sensitive lipase, collagen alpha-3(VI) chain isoform 4 precursor, and Possible J 56 gene 
segment (Fragment). Finally, comparisons across all decellularization methods to identify 
proteins uniquely enriched between the three methods demonstrated that M1 and M2 
uniquely shared 66 proteins not found in either M3 or native tissue. M3 shared one protein 
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uniquely with M2 (Ig kappa chain V-III region B6) and 2 proteins uniquely with M1 
(Alpha-1-acid glycoprotein 2 and Annexin A5).
Bioscaffold implantation in vivo allowed repopulation with mature adipocytes
Subcutaneous implantation was performed using the decellularized M1 and M2 adipose 
scaffolds to determine their support of adipose tissue formation in vivo since they retained 
intact ECM proteins and architecture in vitro; however, comparable studies were not pursued 
using the M3 scaffolds due to the suspension nature of the M3 bioscaffold and its loss of the 
intact tissue architecture during the decellularization process. The M1 and M2 scaffolds 
were implanted subcutaneously into transgenic C57Bl/6 GFP+ mice (Figure 4 and 
Supplemental Figure 1). The scaffolds were harvested at serial intervals (3, 6 and 9 weeks). 
At necropsy, gross visualization of the decellularized adipose scaffolds indicated adipose 
tissue formation equivalent to or more robust than that obtained with a silk scaffold control 
(Supplemental Figure 1). Of note, the M1 and M2 decellularized adipose scaffolds retained 
an architecture similar to native adipose tissue, while the control silk scaffolds constructs 
were more fibrotic in appearance. This was confirmed histologically based on H&E staining 
(Data not shown). The presence of functional adipose cells increased in a time dependent 
manner after implantation based on staining for perilipin, a lipid vacuole membrane 
associated protein (Figure 4). The newly formed adipocytes stained positive for GFP, 
consistent with the ingrowth and repopulation of the scaffold by host origin cells (Figure 4). 
Additionally, the scaffolds contained cells staining positive for CD31, a biomarker primarily 
but not exclusively associated with endothelial cells (Figure 5). An intact, native fat pad 
from transgenic GFP+ C57Bl/6 mice served as a positive control (Figures 4 and 5).
DISCUSSION
Recent studies have reported the preparation of decellularized adipose tissue extracellular 
matrices; a comprehensive review of this literature has recently been published by Banyard 
et al. [25]. While the majority of studies reported on a single decellularization approach, the 
work by Brown et al., stands out as an exception. This publication compared three 
independent methods distinguished based on their predominant reliance on enzymatic, 
chemical or physical methods of decellularizing porcine adipose tissue [30]. They concluded 
that the individual methods resulted in decellularized matrices that were distinct based on 
biochemical and structural features. The current study has confirmed and extended these 
approaches by evaluating human adipose tissues processed with three decellularization 
methods relying on enzymatic, detergent, or solvent agents, respectively. The resulting 
products were examined and compared based on in vitro and in vivo outcomes. Consistent 
with recent mass spectrometry analyses of detergent-decellularized lung tissues, the current 
findings suggest that the proteomic composition of adipose tissue-derived bioscaffolds is 
affected by the chosen decellularization method and this may have implications with respect 
to their utility and favorability for specific clinical translational applications [34].
Despite these differences in the complexity of the decellularized tissue proteome, the 
physical structure of the decellularized adipose product using two methods (M1 and M2) 
was highly similar based on SEM as well as histochemical analyses, including fibrous 
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networks indicative of collagen bundles. Gene ontology analysis of the mass spectroscopic 
proteomic profile was employed to explore the possible functionality of the extracellular 
proteins remaining post-decellularization. All three scaffold preparations displayed common 
functional features related to cell adhesion, biological adhesion, and response to wounding. 
All of the aforementioned functions may prove to be desirable traits for a reconstructive or 
regenerative bioscaffold product designed for a particular or unique application.
Intact genomic DNA retained in decellularized tissues may prove to induce an immune 
response and foreign body reaction by the host to scaffold implants. As such, Gilbert et al. 
have suggested that 50 ng/mg dry weight is a part of the minimum criteria for effective 
decellularization in terms of the amount of genomic DNA remaining in decellularized 
biological scaffolds [43]. This value was approached with both M1 and M2 based on 
spectrophotometric readings; however, Method 3 genomic DNA content exceeded this 
threshold value. The absence or presence of visible nuclear structures based on H&E 
staining complemented the spectrophotometric detection of genomic DNA.
Adipose tissue is distinguished from other tissue types due to its relatively high triglyceride 
content. The decellularization methods were all expected to deplete triglycerides, albeit 
through different mechanisms. Indeed, triglyceride content was found to be highest in 
scaffolds prepared using the detergent based M2. The relative triglyceride content was 
reduced using either enzymatic (M1) or solvent (M3) based approaches. The triglyceride 
retention in the M2 product suggests that the method is less stringent with respect to lipid 
removal. It remains be determined whether the triglyceride content of the decellularized 
adipose product will impact its properties and utility for cosmetic and reconstructive surgery. 
As triglycerides can act to induce adipogenesis at the expense of osteogenesis, the final 
triglyceride content of the product may have potential benefits with respect to soft tissue 
augmentation and reconstruction while being detrimental to bone repair [44].
An important feature of an ideal scaffold product is its retention of the ECM protein content 
and the relative depletion of cytoplasmic and nuclear protein content [43, 45]. The 
cellularized scaffolds displayed an enrichment of ECM proteins based on analyses of the 
mass spectrometry proteomics. This is consistent with the findings based on histochemical 
and SEM analyses, which suggested a well-maintained ECM following decellularization 
independent of the method. Since a critical goal of decellularization is to yield a defined 
ECM product, it was necessary to confirm that the major ECM structural proteins- collagen, 
laminin, fibronectin and elastin were preserved following decellularization. Mass 
spectrometry-based proteomic data from all three decellularization procedures revealed the 
ubiquitous presence of type VI collagen, and a varying presence of laminin and fibronectin. 
While elastin was not detected by mass spectrometry, this does not necessarily rule out its 
presence since certain peptides may be masked by others and thus may not be uncovered 
under this type of analysis. Indeed, the fact that high abundance proteins may interfere with 
the detection of other protein features detected by protein labeling presents a possible 
limitation to the current study. This can lead to a lack of labeling or a false minimal labeling 
with subsequent low detection levels for low abundance proteins. Thus, the LC-MS/MS 
findings herein represent only a subset of the total proteome contained within these 
biological scaffolds. Future studies may need to selectively remove known high abundance 
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proteins to improve sensitivity. Such an approach, using selective antibody depletion of high 
abundance proteins identified in the top twenty hits, has been employed successfully in 
analyses of human serum [46].
Based on mass spectrometry, both the M2 and M3 scaffold preparations retained the largest 
variety of extracellular matrix proteins relative to those detected within intact adipose tissue. 
Additionally, M2 scaffold showed minimal retention of nuclear proteins. In contrast, M1 
displayed a depletion not only of cytoplasmic and nuclear proteins, but resulted in a more 
restricted subset of ECM proteins relative to those found in intact adipose tissue. In this 
respect, M1 yielded the most “homogenous” decellularization product based on the diversity 
of its ECM protein profile as compared to M2 and M3; however, the depletion of 
cytoplasmic and nuclear associated proteins components could alter the biological features 
of the M1 product. Consistent with this observation, Calle et al., using a quantitative [C13] 
labeling mass spectrometry approach, found that the milder detergent based decellularization 
methods differentially extracted and enriched lung matrix proteins [34]. Their comparison 
found that the milder SDS/Triton X-100 detergent increased the yield of basement 
membrane proteins, proteoglycans, and laminin relative to the harsher CHAPS based 
decellularization [34]. Thus, the selection of a particular decellularization protocol can 
significantly influence the composition of final extracellular matrix product. Furthermore, 
the use of mass spectrometry modified to allow for quantitative measurements has merit for 
future studies of the decellularized adipose matrix.
Consistent with previously published studies using adipose-derived ECM prepared using a 
variety of decellularization protocols [10, 11, 14, 15, 17, 20, 28, 32], implantation of 
scaffolds prepared using M1 and M2 demonstrated the ability to promote formation of an 
adipose depot in vivo. The implants displayed a time dependent infiltration of GFP+ 
adipocytes and vascular cells from the adjacent tissues that was accompanied by the 
presence of characteristic mature adipocytes. While only a few scattered cell nuclei were 
detected within the M1 and M2 scaffolds at earlier time points (3 weeks), the number of 
nuclei present based on H&E staining increased considerably at later time points (9 weeks). 
These preliminary in vivo studies validate the ability of M1 and M2 scaffolds to promote 
native cell migration and de novo formation of soft tissue, confirming previous reports in the 
literature [12, 17].
The current study has several limitations that merit consideration with respect to future 
experimentation. First, the MS-based proteomic methods employed were qualitative rather 
than quantitative. The use of [13C] isotope labeled standards, as employed by Calle et al. in 
analyses of the decellularized lung, could address this issue [34]. Additionally, label free 
mass spectrometry methods have been developed which calculate the total protein injected 
into the assay system and use this as a basis for quantifying individual peptide 
concentrations [47]. Second, the current study examined only subcutaneous adipose tissue 
from a limited number of lean (BMI < 25) donors. Future studies will need to compare the 
mass spectrometrically identified proteome of subcutaneous to visceral and other adipose 
depots from lean, overweight, and obese individuals. Baker et al. have pioneered such 
studies by documenting the effect of decellularized extracellular matrix from visceral 
adipose tissue on the metabolism of cultured pre-adipocytes from diabetic and non-diabetic 
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subjects [48]. It will be informative to determine whether correlations exist between the 
metabolic outcomes and the decellularized adipose ECM proteomes as a function of patient 
disease. Finally, the current study did not address the biophysical and mechanical properties 
of the decellularized adipose ECM as had been earlier addressed by Omidi et al. [18]. 
Studies correlating the elasticity, stiffness and compressive properties of the bioscaffolds to 
the proteome as a function of donor and depot origin would extend the scope of the current 
data.
In summary, the decellularization methods explored in this study were chosen based on 
fundamental differences in processing- enzymatic, detergent, and solvent. Each method 
resulted in products with promising features. M1 generated a product with a more narrowly 
focused subset of ECM proteins, yielding a product containing fewer identified cytoplasmic 
and nuclear proteins relative to the other decellularization Methods. M2 successfully 
generated a bioscaffold product isolated without the use of xenogeneic enzymes. This has 
the potential to reduce the likelihood of a subsequent adverse immunologic response or 
foreign body response to the implant by the patient or host. The M3 process was explored 
since it mimics the process used to manufacture commercially available Matrigel™. Since 
Matrigel™ has desirable thermolabile and biomaterial features, such as maintaining a liquid 
form at low temperatures and a solid form at body temperature, a human adipose tissue-
derived bioscaffold would be desirable from a clinical translation perspective for treatments 
requiring small volume injections; however, degradation of the matrix may interfere with its 
utility in larger volume applications. Each of the individual methods has features which may 
provide economies of scale in bioprocessing human adipose tissue commercially. Likewise, 
each method has elements that may prove disadvantageous during the scale-up process. 
Nevertheless, while further work will be necessary to define an optimal decellularization 
method for large scale bioscaffold production, the current study demonstrates that 
comparable ECM products can be obtained with varying combinations of enzymatic, 
detergent, and solvent based decellularization approaches. Eventually, it may prove useful to 
develop a robust and reliable quantitative mass spectrometry lot release assay for the 
characterization and validation of large scale produced decellularized adipose tissue 
matrices.
CONCLUSIONS
The objective of the current study was to compare the proteome of human adipose tissue 
decellularized by multiple methods and to explore its potential application as a scaffold 
promoting adipogenesis in vivo. Based on histological results, human adipose tissue can be 
successfully decellularized using any of three methods involving a combination of 
detergents, enzymes, and/or solvents. Based on mass spectrometric analyses, the resulting 
scaffolds retain a common subset of extracellular matrix proteins; however, the retention of 
cytoplasmic and nuclear proteins varies depending on the extraction methodology. In 
confirmation of prior publications, two of the matrices displayed the ability to promote in 
vivo adipose depot formation through the recruitment of host progenitor cells and 
vasculature. In conclusion, multiple decellularization methods can be applied to human 
adipose tissue to create a product with potential tissue engineering utility; however, the 
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resulting proteome of the decellularized matrix varies dependent on the decellularization 
method.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Microscopic Analysis of Untreated and Decellularized Adipose Tissue Samples. Untreated 
control tissue and the products of the M1, M2, and M3 decellularization procedures were 
evaluated by in H&E staining (top), Masson’s Trichrome stain (middle), and Scanning 
Electron Microscopy (SEM) (shown at 1500 X magnification). Individual images are 
representative of at least n = 3.
Thomas-Porch et al. Page 19














Immunofluorescent staining for collagen VI, actin, and vitronectin. Paraffin fixed slides 
prepared with tissue from untreated controls or scaffolds decellularized using methods M1 
and M2 were stained with fluorochrome labeled antibodies to collagen VI, actin, and 
vitronectin. Images are representative of n =3.
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Subcellular Localization of the Top Twenty Peptides (based on number of hits) in Each 
Decellularized Scaffold Relative to Untreated Tissue Control.
Thomas-Porch et al. Page 21














Immunohistochemical Detection of Adipogenic Biomarker (Perilipin) and Host Cells (GFP) 
in M1 and M2 Tissue Scaffold In Vivo Implants. Scaffolds were implanted into C57BL/6 
mice transgenic for ubiquitous expression of the green fluorescent protein (GFP) for periods 
of 3, 6, or 9 weeks (top, middle, or bottom panels). A native adipose tissue served as positive 
controls for both antibodies.
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Immunofluorescent Detection of CD 31. demonstrated the vascularization of the implanted 
scaffolds denoting their integration. Scaffolds were implanted into C57BL/6 mice transgenic 
for ubiquitous expression of the green fluorescent protein (GFP) for periods of 3 or 6 weeks. 
A silk scaffold implant and native adipose tissue served as positive controls. Sections were 
stained with DAPI for detection of nuclei (blue) or anti-CD31 fluorochrome labeled 
antibodies (red).
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Table 1
Genomic DNA and Triglyceride Levels in Decellularized Human Adipose-Derived Scaffolds
Untreated Decell M1 Decell M2 Decell M3
Genomic DNA (ng/μl) 281 ± 152 47 ± 21* 37 ± 9* 237 ± 221
Triglyceride (mg/dl) 56.8 ± 0.2 16.9 ± 0.1 23.7 ± 0.1 16.8 ± 0.1
Values are reported as the mean ± standard deviation of n = 3 samples from individual donors. Significance was calculated based on a one tailed 
student t-test relative to the untreated control where (*) represents p value < 0.05.
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Table 2
LC-MS/MS Peptides Identified with each Decellularization Method
Untreated Decell M1 Decell M2 Decell M3
# Identified Peptides 281 66 296 242
# Identified with 2 Peptides 155 25 143 102
# Identified with 7 Peptides 29 1 30 15



































































































































































































































































































































































































































































J Biomed Mater Res A. Author manuscript; available in PMC 2019 September 01.
